3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
3
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Motor Activity
1
Hyperthermia
1
Head and Neck Neoplasms
1
Colorectal Neoplasms
1
Carcinoma
1
Interventions
Ifosfamide
4
Paclitaxel
3
Thiotepa
2
Peripheral Blood Stem Cell Transplantation
2
Flow Cytometry
2
Filgrastim
2
Cisplatin
2
Carboplatin
2
Amplified Fragment Length Polymorphism Analysis
2
tremelimumab
1
thymoglobulin
1
pembrolizumab
1
palifosfamide lysine
1
isophosphamide mustard
1
etoposide phosphate
1
durvalumab
1
cabazitaxel
1
Vinblastine
1
Stem Cell Transplantation
1
Rituximab
1
Radiotherapy
1
Polymerase Chain Reaction
1
Mycophenolic Acid
1
Moxifloxacin
1
Microarray Analysis
1
Melphalan
1
In Situ Hybridization
1
Immunologic Techniques
1
Immunohistochemistry
1
Immunoenzyme Techniques
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Testicular Neoplasms
×
Control Groups
×
Clear all
NCT02577172
2017-01-26
TAST
Oslo University Hospital
Phase NA
Terminated
19 enrolled